Takeda Buys Out Partner GammaDelta In Cell Therapy Push
Lead Asset Newly In Phase I
Japanese major buys out existing cancer cell therapy research partner, exercising an exclusive option dating back to a 2017 collaboration and expanding its immuno-oncology ambitions and pipeline.
